[go: up one dir, main page]

SV2009002862A - Composiciones de suplementos de hierro de tolerancia mejorada - Google Patents

Composiciones de suplementos de hierro de tolerancia mejorada

Info

Publication number
SV2009002862A
SV2009002862A SV2008002862A SV2008002862A SV2009002862A SV 2009002862 A SV2009002862 A SV 2009002862A SV 2008002862 A SV2008002862 A SV 2008002862A SV 2008002862 A SV2008002862 A SV 2008002862A SV 2009002862 A SV2009002862 A SV 2009002862A
Authority
SV
El Salvador
Prior art keywords
compositions
improved tolerance
iron supplements
mammals
deficient
Prior art date
Application number
SV2008002862A
Other languages
English (en)
Inventor
Peter Krebs
Allison Krebs-Bensch
Jerome Mincy
Original Assignee
Grace Procurements Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37902204&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SV2009002862(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grace Procurements Llc filed Critical Grace Procurements Llc
Publication of SV2009002862A publication Critical patent/SV2009002862A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A COMPOSICIONES PARA TRATAR O PREVENIR LA DEFICIENCIA FÉRRICA EN LOS MAMÍFEROS, Y EN PARTICULAR EN LOS HUMANOS, ADMINISTRANDO A MAMÍFEROS CON DEFICIENCIA FÉRRICA O POTENCIALMENTE DEFICIENTES UNA CANTIDAD EFICAZ DE UNA COMPOSICIÓN QUE CONTIENE UNA SAL DE HIERRO FARMACÉUTICAMENTE ACEPTABLE, Y UN COMPLEJO DE POLISACÁRIDO DE HIERRO
SV2008002862A 2005-10-04 2008-04-04 Composiciones de suplementos de hierro de tolerancia mejorada SV2009002862A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/243,043 US20070077313A1 (en) 2005-10-04 2005-10-04 Toleration iron supplement compositions

Publications (1)

Publication Number Publication Date
SV2009002862A true SV2009002862A (es) 2009-01-27

Family

ID=37902204

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2008002862A SV2009002862A (es) 2005-10-04 2008-04-04 Composiciones de suplementos de hierro de tolerancia mejorada

Country Status (10)

Country Link
US (2) US20070077313A1 (es)
EP (1) EP1945032A4 (es)
CA (1) CA2624619C (es)
CR (1) CR9857A (es)
CU (1) CU23776B7 (es)
EC (1) ECSP088348A (es)
HN (1) HN2008000582A (es)
SV (1) SV2009002862A (es)
TW (1) TWI358299B (es)
WO (1) WO2007044180A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
ES2426445T3 (es) * 2006-04-07 2013-10-23 Merrion Research Iii Limited Forma de dosificación oral sólida que contiene un potenciador
KR20110007614A (ko) * 2008-05-07 2011-01-24 메리온 리서치 Ⅲ 리미티드 ＧｎＲＨ 관련 화합물의 조성물 및 제조 방법
JP2012518686A (ja) * 2009-02-25 2012-08-16 メリオン・リサーチ・Ｉｉｉ・リミテッド ビスホスホネート類の組成物および薬物送達
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
WO2011120033A1 (en) * 2010-03-26 2011-09-29 Merrion Research Iii Limited Pharmaceutical compositions of selective factor xa inhibitors for oral administration
AU2012204213A1 (en) * 2011-01-07 2013-06-13 Merrion Research Iii Limited Pharmaceutical compositions of iron for oral administration
CN102167752B (zh) * 2011-05-23 2012-08-08 华南理工大学 一种水溶性大豆多糖亚铁配合物的制备方法
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
ES2975708T3 (es) 2015-01-29 2024-07-12 Novo Nordisk As Comprimidos que comprenden agonista del GLP-1 y recubrimiento entérico
WO2022198329A1 (en) * 2021-03-26 2022-09-29 Alberta Veterinary Laboratories Ltd. Water-based iron supplement formulations for dosing animal neonates

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821192A (en) * 1971-08-18 1974-06-28 Central Pharmacal Co Process for preparing an iron-saccharide complex
IT1251702B (it) * 1991-10-16 1995-05-19 Mediolanum Farmaceutici Srl Complessi del ferro con la conalbumina e i suoi derivati
WO2000061191A2 (en) * 1999-04-09 2000-10-19 Advanced Magnetics, Inc. Heat stable coated colloidal iron oxides
US20030190355A1 (en) * 2002-04-05 2003-10-09 Hermelin Marc S. Modified release minerals
US7994217B2 (en) * 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
ES2358151T3 (es) * 2002-08-15 2011-05-06 Euro-Celtique S.A. Composiciones farmacéuticas que comprenden un antagonista opioide.
US7569560B2 (en) * 2004-03-19 2009-08-04 Warner Chilcott Company Llc Extended cycle multiphasic oral contraceptive method
US7585527B2 (en) * 2005-09-19 2009-09-08 Bala Venkataraman Composition and method for treating iron deficiency anemia

Also Published As

Publication number Publication date
ECSP088348A (es) 2008-07-30
CA2624619A1 (en) 2007-04-19
EP1945032A2 (en) 2008-07-23
EP1945032A4 (en) 2009-04-15
CU23776B7 (es) 2012-02-15
CA2624619C (en) 2018-03-13
WO2007044180A2 (en) 2007-04-19
CR9857A (es) 2008-07-29
US20110052722A1 (en) 2011-03-03
HN2008000582A (es) 2011-11-09
TWI358299B (en) 2012-02-21
US20070077313A1 (en) 2007-04-05
WO2007044180A3 (en) 2007-07-12
CU20080054A7 (es) 2010-08-30

Similar Documents

Publication Publication Date Title
SV2009002862A (es) Composiciones de suplementos de hierro de tolerancia mejorada
BRPI0915536A2 (pt) salicilatos acetilados de ácidos graxos e seus usos
ECSP099634A (es) Derivados de piridazinona útiles como inhibidores de glucano sintasa
SV2009003335A (es) Formulaciones para el cancer
MX384206B (es) Formulaciones de inhibidores de dpp iv
BRPI0708965B8 (pt) composição farmacêutica de metilnaltrexona
CR11418A (es) Trans-clomifeno para el sindrome metabolico
CR10566A (es) Compuestos heterociclicos adecuados para el tratamiento de enfermedades relacionadas con nivel elevado de lipidos
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
UY31209A1 (es) Uso de homo y copolimeros para la estabilización de formulaciones de principios activos
ECSP10010344A (es) Azolilmetiloxiranos, su uso y agentes que los contienen
UY30215A1 (es) Derivados de cromanol sustituidos, procedimientos para su preparacion, composiciones farmacéuticas que los contienen y aplicaciones
MX2011007101A (es) Composiciones de hidrolizados proteicos que tienen capacidad mejorada para liberar colecistocinina (cck).
CL2012000392A1 (es) Uso de un anticuerpo anti-cd20 afucosilado con una cantidad de fucosa de 60% o menos para tratar cancer en combinacion con fludarabina .
NO20070580L (no) Behandling av cancer.
GT200600520A (es) Agentes antibacterianos
CL2004000535A1 (es) Composicion farmaceutica que comprende rapamicina o un derivado de rapamicina y pimecrolimus; y su uso para el tratamiento de enfermedad inflamatoria del intestino.
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
TW200726460A (en) Anti-fatigue composition
BRPI0606528A2 (pt) composição para uso no fabrico de medicamentos de tratamento da infertilidade masculina e uso da mesma
NI200700218A (es) Derivados de amida como ligandos de canales iónicos y composiciones farmacéuticas y métodos para usar los mismos.
ECSP088899A (es) Derivados de 2-alcoxi-3,4,5-trihidroxi-alquilamida, su preparación, composiciones que las contienen y utilización
ECSP088893A (es) 2-alcoxi-3, 4,5-trihidroxi-alquilamida-benzazepinas, su preparación, composiciones que las contienen y utilización
BR112015025101A2 (pt) composição antitumoral que compreende um inibidor pi3kbeta-seletivo e um inibidor pi3kalfa-seletivo
ECSP088897A (es) 2-alcoxi-3,4,5-trihidroxi-alquilamida-benzotiazepinas, su preparación, composiciones que las contienen y utilización